What's new in Interventional Cardiology

Designed By & For you, PCRonline offers a wealth of constantly updated information on interventional cardiovascular medicine. Whether you’re looking for the latest articles, cases, course presentations or videos, check out these pages regularly, or better yet, sign up for our newsletter and remain in the know!

Filter By

92 results

CLOSURE-AF: left atrial appendage closure or medical therapy in atrial fibrillation

23 Mar 2026

Catheter-based left atrial appendage closure (LAAC) is widely used as an alternative to oral anticoagulation in atrial fibrillation. But how does it compare with best medical therapy in patients at high risk of both stroke and bleeding? The CLOSURE-AF trial provides new data to inform this...

Reviewer

Salvatore Brugaletta
LAAC vs medical therapy: insights from CLOSURE-AF

Intravascular lithotripsy or mechanical debulking in complex calcified coronary arteries: multicenter, prospective ROLLING STONE study

19 Mar 2026

The ROLLING STONE registry compares intravascular lithotripsy (IVL) and atherectomy (rotational and orbital) for treating heavily calcified coronary arteries, assessing real-world safety and effectiveness in percutaneous coronary interventions (PCI).

Reviewer

Aaysha Cader
Intravascular lithotripsy or mechanical debulking in complex calcified coronary arteries: multicenter, prospective ROLLING STONE study

Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: final 7-year results of the COMPARE-ABSORB trial

10 Mar 2026

This study provides the longest available follow-up for first-generation bioresorbable vascular scaffolds and fails to demonstrate any late clinical advantage after complete scaffold resorption.

Emanuele Gallinoro

Reviewer

Emanuele Gallinoro
Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: final 7-year results of the COMPARE-ABSORB trial

Drug-coated balloon angioplasty vs up-front stenting for de novo CAD: 3-year follow-up of REC-CAGEFREE I trial

10 Mar 2026

The 3-year follow-up of the REC-CAGEFREE I trial demonstrated that a DCB-based strategy with rescue stenting was associated with a significantly higher rate of DOCE compared with contemporary DES implantation in patients with de novo, non-complex coronary artery disease.

Reviewer

Ali Nazmi Calik
Murat Gökalp

Reviewer

Murat Gökalp
Drug-coated balloon angioplasty vs up-front stenting for de novo CAD: 3-year follow-up of REC-CAGEFREE I trial

Aspirin discontinuation timing with ticagrelor monotherapy in ACS: a post hoc analysis from TICO and T-PASS

11 Mar 2026

The TICO1 and T-PASS2 trials evaluated abbreviated DAPT followed by ticagrelor monotherapy compared to DAPT in patients with ACS undergoing PCI. Both trials demonstrated the safety and efficacy of abbreviated DAPT however, the optimal timing of aspirin discontinuation remains uncertain. This post hoc analysis compares the...

Nicola Ryan

Reviewer

Nicola Ryan
Optimal timing of aspirin discontinuation with ticagrelor monotherapy in ACS: insights from TICO and T-PASS

When a surgical valve needs a second life

27 Feb 2026

A 79-year-old patient previously treated with surgical aortic valve replacement was referred after an episode of acute cardiac decompensation. Although clinically stabilised, further evaluation revealed degeneration of the bioprosthesis, and mixed aortic valve pathology.

This case focuses on the diagnostic assessment and the strategic considerations guiding the...

Christina Grothusen

Author

Christina Grothusen
When a surgical valve needs a second life

Interdisciplinary therapeutic strategy in a low-risk patient with aortic stenosis and preserved life expectancy

05 Mar 2026

A 71-year-old low-risk patient with symptomatic severe aortic stenosis and preserved ventricular function presents with progressive dyspnoea and chest pain. With long life expectancy, the choice of treatment demands careful interdisciplinary planning. How would you treat?

Conradi Lenard

Author

Lenard Conradi

Author

Ole De Backer

Author

Alper Öner
Thomas Pilgrim

Author

Thomas Pilgrim
Interdisciplinary therapeutic strategy in a low-risk patient with aortic stenosis and preserved life expectancy

How should I treat a torrential tricuspid valve regurgitation in a young patient who remains symptomatic despite optimal medical therapy?

19 Feb 2026

A frail patient presents with worsening NYHA class III dyspnoea and peripheral oedema despite optimal medical therapy. Previously managed conservatively, severe tricuspid regurgitation has progressed to a torrential grade, with right-sided chamber dilatation and complex valve anatomy.

How would you treat this patient?

Eike Philipp Tigges

Author

Eike Philipp Tigges
Tim Ubben

Author

Timm Ubben
How should I treat a torrential tricuspid valve regurgitation in a young patient who remains symptomatic despite optimal medical therapy?

PCRonline @ ACC.26 Scientific Sessions

12 Mar 2026

Live updates on a selection of major Late Breaking Clinical Trials of interest in interventional cardiology presented at the American College of Cardiology 2026 Scientific Sessions #ACC26

PCRonline @ ACC.26 Scientific Sessions

LAA closure with CT planning: challenging inferior chicken wing morphology

11 Feb 2026

This 77-year-old woman with paroxysmal AF and prior GI bleeding is referred for LAA closure, but CT reveals a shallow, inferior chicken-wing morphology that complicates device selection and planning. How would your Heart Team approach this challenging case?

Martin W. Bergmann

Author

Martin W. Bergmann
LAA closure with CT planning: challenging inferior chicken wing morphology